The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose level

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 5, 1996, Pages 1975-1978

  Castillo, Manuel J ^b   Scheen, André J ^a   Lefèbvre, Pierre J ^a,c  

^a CHU SART TILMAN   (Belgium)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; C PEPTIDE; FATTY ACID; GLUCAGON; GLUCOSE; GLYCEROL; GROWTH HORMONE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DETERIORATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOGLYCEMIA; INSULIN INFUSION; KETOGENESIS; LIPOLYSIS; MALE; METABOLIC REGULATION; PRIORITY JOURNAL;

3-HYDROXYBUTYRIC ACID; ADULT; BLOOD GLUCOSE; CIRCADIAN RHYTHM; DIABETES MELLITUS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCAGON; GLYCEROL; GROWTH HORMONE; HUMANS; HYDROXYBUTYRATES; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED;

EID: 0029986037     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.5.1975     Document Type: Article

References (19)

1. The Diabetes Control and Complication Trial Research Group. 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 329:977-986.
2. Hirsch IB, Farkas-Hirsch R, Skyler JS. 1990 Intensive insulin therapy for treatment of type I diabetes. Diabetes Care. 13:1265-1283.
3. Skyler JS. 1989 Continuous subcutaneous insulin infusion (CSII) with external devices: current status. In: Ensminger WD, Selam JL, eds. Update in Drug Delivery Systems. Mount Kisco, NY: Futura; 163-183.
4. Bruttomesso D, Barberio S, Fongher C, et al. 1992 Retrospective analysis of daily glucose profile in type 1 diabetic patients with continuous subcutaneous insulin infusion (CSII). Diabet Res Clin Pract. 16:197-202.
5. Kitabchi AE, Fisher JN, Matteri R, Murphy MB. 1983 The use of continuous insulin delivery systems in treatment of diabetes mellitus. Ann Intern Med. 28:449-490.
6. Home PD, Marshall SM. 1984 Problems and safety of continuous subcutaneous insulin infusion. Diabetic Med. 1:41-44.
7. Castillo MJ, Scheen AJ, Lefèbvre PJ. 1995 Treatment with insulin infusion pumps and ketoacidotic episodes: From physiology to troubleshooting. Diabetes Metab Rev. 11:161-177.
8. Selam JL, Charles MA. 1990 Devices for insulin administration. Diabetes Care. 13:955-979.
9. Krzentowski G, Scheen A, Castillo M, Luyckx AS, Lefèbvre PJ. 1983 A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control. Diabetologia. 24:314-318.
10. Scheen A, Castillo M, Jandrain B, et al. 1984 Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients. Diabetes Care. 7:338-342.
11. Lefèbvre PJ, Luyckx AS, Scheen AJ, Castillo M, Jandrain B, Krzentowski G. 1984 Conséquences métaboliques de la carence en insuline. In: J. Diabétologie Hotel Dieu. Paris: Flamarion Médecine-Sciences; 163-174.
12. Kraegen EW, Chisholm DG. 1985 Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy. Clin Pharmacokinet. 10:303-314.
13. Scheen AJ. 1989 Pharmacocinétique de l'insuline administrée par voie souscutanée. Application au traitement par pompe portable. Diabete Metab. 15: 128-138.
14. Bergmann RN, Steil GM, Bradley DC, Watanabe RM. 1992 Modeling of insulin action in vivo. Annu Rev Physiol. 54:861-883.
15. Vaughan VJA, Rao RH, Kurtz AB, Buckell HM, Spathis GS. 1986 Strict nocturnal diabetic control diminishes subsequent glycemic escape during acute insulin withdrawal. Metabolism. 35:136-142.
16. Fanelli C, Pampanelli S, Epifano L, et al. 1994 Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia. 37:1265-1276.
17. Scheen AJ, Krzentowski G, Castillo M, Lefèbvre PJ, Luyckx AS. 1983 A 6 hour nocturnal interruption of a continuous subcutaneous insulin infusion. 2. Marked attenuation of the metabolic deterioration by somatostatin. Diabetologia. 24:319-325.
18. Castillo MJ, Scheen AJ, Gualda P, Lefèbvre PJ. 1989 Papel de la insulina y hormonas de la contra-regulación en las alteraciones metabólicas por deprivación de insulina en pacientes diabéticos. Rev Esp Fisiol. 45:53-60.
19. Scheen AJ, Gillet J, Rosenthaler J, et al. 1989 Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients. Diabetologia. 32:801-809.